Biopsy groups | P value | |||
---|---|---|---|---|
Image-guided | Systematic | Odds ratio (95% CI) | ||
Pathological stagea, % (n) | 0.86 (0.31–2.34) | .736 | ||
≤ pT2b | 14.3 (11) | 12.5 (11) | ||
≥ pT2c | 85.7 (66) | 87.5 (77) | ||
Clinical stagea, % (n) | 10.35 (4.60–24.99) | < .001* | ||
≤ cT2b | 14.3 (11) | 63.6 (56) | ||
≥ cT2c | 85.7 (66) | 36.4 (32) | ||
Stage agreement, % (n) | ||||
Correct | 89.6 (69) | 46.6 (41) | ||
Over graded | 5.2 (4) | 1.1 (1) | ||
Under graded | 5.2 (4) | 52.3 (46) | ||
Cohen’s Kappa (95% CI) | 0.58 (0.35 0.80) | 0.11 (0.0 0.22) | ||
Pathological Gleasona, % (n) | 10.35 (4.60–24.99) | .268 | ||
≤ 3 + 4 | 40.3 (31) | 48.9 (43) | ||
≥ 4 + 3 | 59.7 (46) | 51.1 (45) | ||
Biopsy Gleasona, % (n) | 3.36 (1.69–6.84) | < .001* | ||
≤ 3 + 4 | 29.9 (23) | 59.1 (52) | ||
≥ 4 + 3 | 70.1 (54) | 40.9 (36) | ||
Gleason score agreement, % (n) | ||||
Correct | 81.8 (63) | 76.1 (67) | ||
Over graded | 14.3 (11) | 6.8 (6) | ||
Under graded | 3.9 (3) | 17 (15) | ||
Cohen’s Kappa (95% CI) | 0.61 (0.39 0.82) | 0.53 (0.32 0,73) |